What the Research Says
Lactobacillus is the most extensively studied probiotic genus with thousands of clinical trials. The evidence base is strongest for L. rhamnosus GG (AAD prevention, pediatric diarrhea), L. plantarum 299v (IBS), L. reuteri DSM 17938 (infantile colic), and L. acidophilus (lactose digestion). A critical principle is strain specificity — clinical benefits are tied to specific strains, not the genus as a whole. The AGA conditionally recommends L. rhamnosus GG for AAD prevention and L. reuteri for infantile colic based on moderate-quality evidence.
